NCT00652392 Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM Status COMPLETED Phase PHASE3
NCT00652002 Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5 Status COMPLETED Phase PHASE3
NCT00651651 Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5 Status COMPLETED Phase PHASE3
NCT00649025 A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults Status COMPLETED Phase PHASE3
NCT00646789 A Study to Evaluate the Safety, Tolerability and Plasma Concentration Profiles of MK0633 in Asthmatic Children Aged 12 to Less Than 16 Years (0633-019) Status COMPLETED Phase PHASE1
NCT00646529 Long-Term Safety of Symbicort in Asthmatic Children - SAPLING Status COMPLETED Phase PHASE3
NCT00646321 Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT Status COMPLETED Phase PHASE3
NCT00643578 Dose-response of Inhaled Formoterol Using Methacholine Challenge as a Bioassay Status COMPLETED Phase NA
NCT00642616 Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease Status TERMINATED Phase PHASE3
NCT00641914 Inhaled Steroid Treatment as Regular Therapy in Early Asthma Status COMPLETED Phase PHASE4
NCT00641472 Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, Children Status COMPLETED Phase PHASE4